Erschienen in:

01.08.2004 | ORIGINAL CONTRIBUTION

A prospective, multicenter, open-label assessment of atomoxetine in non-North American children and adolescents with ADHD

verfasst von: Jan K. Buitelaar, M. D., Ph. D., Marina Danckaerts, Christopher Gillberg, Alessandro Zuddas, Katja Becker, Manuel Bouvard, Jenny Fagan, Julia Gadoros, Valerie Harpin, Philip Hazell, Mats Johnson, Tally Lerman-Sagie, Cesar A. Soutullo, Tomasz Wolanczyk, Pal Zeiner, Daniel S. Fouche, Judith Krikke-Workel, Shuyu Zhang, David Michelson, for the Atomoxetine International Study Group

Erschienen in: European Child & Adolescent Psychiatry | Ausgabe 4/2004